Literature DB >> 24601752

MR imaging of the substantia nigra at 7 T enables diagnosis of Parkinson disease.

Mirco Cosottini1, Daniela Frosini, Ilaria Pesaresi, Mauro Costagli, Laura Biagi, Roberto Ceravolo, Ubaldo Bonuccelli, Michela Tosetti.   

Abstract

PURPOSE: To evaluate the anatomy of the substantia nigra (SN) in healthy subjects by performing 7-T magnetic resonance (MR) imaging of the SN, and to prospectively define the accuracy of 7-T MR imaging in distinguishing Parkinson disease (PD) patients from healthy subjects on an individual basis.
MATERIALS AND METHODS: The 7-T MR imaging protocol was approved by the Italian Ministry of Health and by the local competent ethics committee. SN anatomy was described ex vivo on a gross brain specimen by using highly resolved proton-density (spin-echo proton density) and gradient-recalled-echo (GRE) images, and in vivo in eight healthy subjects (mean age, 40.1 years) by using GRE three-dimensional multiecho susceptibility-weighted images. After training on appearance of SN in eight healthy subjects, the SN anatomy was evaluated twice by two blinded observers in 13 healthy subjects (mean age, 54.7 years) and in 17 PD patients (mean age, 56.9 years). Deviations from normal SN appearance were described and indicated as abnormal, and both diagnostic accuracy and intra- and interobserver agreement for diagnosis of PD with 7-T MR imaging were calculated.
RESULTS: Three-dimensional multiecho susceptibility-weighted 7-T MR imaging reveals a three-layered organization of the SN allowing readers to distinguish pars compacta ventralis and dorsalis from pars reticulata. The abnormal architecture of the SN allowed a discrimination between PD patients and healthy subjects with sensitivity and specificity of 100% and 96.2% (range, 92.3%-100%), respectively. Intraobserver agreement (κ = 1) and interobserver agreement (κ = 0.932) were excellent.
CONCLUSION: MR imaging at 7-T allows a precise characterization of the SN and visualization of its inner organization. Three-dimensional multiecho susceptibility-weighted images can be used to accurately differentiate healthy subjects from PD patients, which provides a novel diagnostic opportunity.

Entities:  

Mesh:

Year:  2014        PMID: 24601752     DOI: 10.1148/radiol.14131448

Source DB:  PubMed          Journal:  Radiology        ISSN: 0033-8419            Impact factor:   11.105


  54 in total

1.  Signal Alteration of Substantia Nigra on 3.0T Susceptibility-weighted Imaging in Parkinson's Disease and Vascular Parkinsonism.

Authors:  Xue-Jun Zhao; Xi-Yuan Niu; He-Yang You; Min Zhou; Xue-Bing Ji; Ying Liu; Lei Wu; Xiao-Ling Ding
Journal:  Curr Med Sci       Date:  2019-10-14

2.  Diagnostic performance of loss of nigral hyperintensity on susceptibility-weighted imaging in parkinsonism: an updated meta-analysis.

Authors:  Pyeong Hwa Kim; Da Hyun Lee; Chong Hyun Suh; Minjae Kim; Woo Hyun Shim; Sang Joon Kim
Journal:  Eur Radiol       Date:  2021-01-15       Impact factor: 5.315

3.  Nigrosome 1 Detection at 3T MRI for the Diagnosis of Early-Stage Idiopathic Parkinson Disease: Assessment of Diagnostic Accuracy and Agreement on Imaging Asymmetry and Clinical Laterality.

Authors:  Y Noh; Y H Sung; J Lee; E Y Kim
Journal:  AJNR Am J Neuroradiol       Date:  2015-08-20       Impact factor: 3.825

Review 4.  Susceptibility-weighted imaging and quantitative susceptibility mapping in the brain.

Authors:  Chunlei Liu; Wei Li; Karen A Tong; Kristen W Yeom; Samuel Kuzminski
Journal:  J Magn Reson Imaging       Date:  2014-10-01       Impact factor: 4.813

5.  Ultra-high-field MR imaging in polymicrogyria and epilepsy.

Authors:  A De Ciantis; A J Barkovich; M Cosottini; C Barba; D Montanaro; M Costagli; M Tosetti; L Biagi; W B Dobyns; R Guerrini
Journal:  AJNR Am J Neuroradiol       Date:  2014-09-25       Impact factor: 3.825

6.  Nigral involvement in atypical parkinsonisms: evidence from a pilot study with ultra-high field MRI.

Authors:  Daniela Frosini; Roberto Ceravolo; Michela Tosetti; Ubaldo Bonuccelli; Mirco Cosottini
Journal:  J Neural Transm (Vienna)       Date:  2016-03-04       Impact factor: 3.575

Review 7.  Substantia nigra fractional anisotropy is not a diagnostic biomarker of Parkinson's disease: A diagnostic performance study and meta-analysis.

Authors:  Fabiana C C Hirata; João R Sato; Gilson Vieira; Leandro T Lucato; Claudia C Leite; Edson Bor-Seng-Shu; Bruno F Pastorello; Maria C G Otaduy; Khallil T Chaim; Kenia R Campanholo; Natalia P Novaes; Luciano Magalhães Melo; Márcia R Gonçalves; Felipe Barjud Pereira do Nascimento; Manoel Jacobsen Teixeira; Egberto Reis Barbosa; Edson Amaro; Ellison Fernando Cardoso
Journal:  Eur Radiol       Date:  2016-10-05       Impact factor: 5.315

Review 8.  Advanced magnetic resonance imaging of neurodegenerative diseases.

Authors:  Federica Agosta; Sebastiano Galantucci; Massimo Filippi
Journal:  Neurol Sci       Date:  2016-11-15       Impact factor: 3.307

9.  High-Spatial-Resolution Diffusion MRI in Parkinson Disease: Lateral Asymmetry of the Substantia Nigra.

Authors:  Zheng Zhong; Douglas Merkitch; M Muge Karaman; Jiaxuan Zhang; Yi Sui; Jennifer G Goldman; Xiaohong Joe Zhou
Journal:  Radiology       Date:  2019-02-19       Impact factor: 11.105

10.  Quantifying changes in nigrosomes using quantitative susceptibility mapping and neuromelanin imaging for the diagnosis of early-stage Parkinson's disease.

Authors:  Hiroto Takahashi; Yoshiyuki Watanabe; Hisashi Tanaka; Masahito Mihara; Hideki Mochizuki; Tian Liu; Yi Wang; Noriyuki Tomiyama
Journal:  Br J Radiol       Date:  2018-05-17       Impact factor: 3.039

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.